Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
Raymond L. Comenzo(Memorial Sloan Kettering Cancer Center), Giampaolo Merlini(University of Pavia), Vaishali Sanchorawala(Boston University), Morie A. Gertz(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic in Arizona), David C. Seldin(Boston University), Donna Reece(Princess Margaret Cancer Centre), Ashutosh Wechalekar(Boston University), Rodney H. Falk(Boston University), Jeff Zonder(Wayne State University), Giovanni Palladini(University of Pavia), Karen Wells(University of Tennessee at Knoxville), Alina Solomon(Stockholm University), Howard Streicher(National Cancer Institute), Angela Dispenzieri(WinnMed), M Skinner, Heather Landau(Memorial Sloan Kettering Cancer Center)
Cited by 383
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k